|

CD45RA depleted donor lymphocyte infusion (DLI) Clinical Trials

2 actively recruiting trials

▲ +1 trial since June 2026

Pipeline

Phase 1/2: 2

Top Sponsors

  • University Hospital Tuebingen1
  • Ruijin Hospital1

Indications

  • Hematologic Malignancy2
  • Cancer2
  • Haplo-identical HCT1

Other2 trials

CD45RA Depleted DLI After TCRα/β Depleted Haploidentical HCT
Phase 1/2
CD45RA-depleted DLI for the Treatment of Refractory/Persistent Viral Infections After Haploidentical Transplantation
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.